title: Pharmacokinetics of recombinant human erythropoietin after SC administration and in long-term IV treatment in patients on maintenance hemodialysis.
authors.affiliation: Department of Internal Medicine and Nephrology, Klinikum Steglitz, Freie Universität Berlin, FRG.
authors.forename: H H
authors.initials: HH
authors.lastname: Neumayer
authors.forename: J
authors.initials: J
authors.lastname: Brockmöller
authors.forename: E
authors.initials: E
authors.lastname: Fritschka
authors.forename: I
authors.initials: I
authors.lastname: Roots
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
authors.forename: M
authors.initials: M
authors.lastname: Wattenberg
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004921:Erythropoietin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007674:Kidney Diseases / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
chemical_list: D004921:Erythropoietin